ELISA Kit for Antibody Detection Against African Swine Fever Virus Market: Opportunity by 2034 | In-Depth Report

ELISA Kit for Antibody Detection Against African Swine Fever Virus by Application (Scientific Research, Veterinary Clinic, Farm, Other), by Types (Competitive ELISA, Indirect ELISA, Sandwich ELISA), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 166

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 166

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Size | CAGR 12.5 Forecast 2033

ELISA Kit for Antibody Detection Against African Swine Fever Virus Market: Opportunity by 2034 | In-Depth Report

🏭 Healthcare🌍 Global

Pages: 166

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 166

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Overview

The ELISA Kit for Antibody Detection Against African Swine Fever Virus market comprises immunoassays that enable rapid, high‑throughput screening of swine sera for ASFV‑specific antibodies, a critical tool for disease surveillance and control. This market is pivotal as ASF continues to threaten global pork production, prompting governments and producers to invest heavily in diagnostic capacity. The ELISA Kit for Antibody Detection Against African Swine Fever Virus market size was estimated at approximately USD 340 million in 2025, with a robust growth outlook driven by a projected CAGR of 12% from 2026 to 2033. The market forecast reflects accelerating industry expansion across Asia‑Pacific, Europe, and emerging Latin American economies. Key macro drivers include recurring ASF outbreaks, stringent regulatory mandates for mandatory reporting, and rising public‑private partnerships funding diagnostic infrastructure. The sector is shaped by three dominant forces: (1) regulatory pressure mandating routine serological monitoring, (2) technological advances such as recombinant antigens and multiplex ELISA platforms, and (3) intensified competition among global players like IDvet, Thermo Fisher Scientific, and Ingenasa, which is spurring price‑performance innovations.

Loading chart…

Geographically, Asia‑Pacific remains the largest market, anchored by China’s extensive pork industry and aggressive ASF containment programs. Meanwhile, Latin America emerges as the fastest‑growing region, driven by recent incursions in Brazil and Argentina and expanding veterinary diagnostic networks. Supply‑chain resilience, especially the scaling of recombinant antigen production, will be essential to meet rising demand. Collectively, these dynamics position the ELISA kit segment as a cornerstone of global ASF mitigation strategies, offering strategic opportunities for investors, biotech firms, and policy makers aiming to safeguard swine health and food security.

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	307.89 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; AffiGEN; BioStone; Cusabio; BioChek; Vazyme; Elabscience; Abbexa; Biovetest; Sino-science Gene; Beijing Mingrida Science and Technology; Wuhan Keqian Biology; Zhenrui Biotech; Zhonghai Biotech; RocGene; Senkang Biotechnology; Huapai Biotechnology; ProtTech; Zhengzhou Zhongdao Biotechnology; Guosheng Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The ELISA Kit for Antibody Detection Against African Swine Fever Virus market is being reshaped by heightened biosecurity mandates, expanding swine production in emerging economies, and accelerating assay automation. As governments tighten disease‑surveillance regulations and pork consumption rebounds post‑COVID‑19, the market size is projected to expand at a robust growth forecast through 2032, creating a strategic imperative for manufacturers to align product pipelines with evolving diagnostic standards.

Growth Drivers2 items

Rising incidence of African Swine Fever across Asia and Eastern Europe fuels demand for rapid, high‑throughput ELISA kits, directly boosting the ELISA Kit for Antibody Detection Against African Swine Fever Virus market size.

Government‑backed surveillance programs and subsidies for disease‑free certification accelerate kit adoption, while integrated data‑management platforms enhance assay efficiency and justify premium pricing.

Restraints2 items

Stringent validation requirements for cross‑reactivity and specificity prolong time‑to‑market, limiting short‑term revenue streams for new entrants and compressing the market’s growth momentum.

Volatile raw‑material costs for high‑purity antigens and conjugates erode margin stability, prompting price sensitivity among large‑scale pork producers and constraining market expansion.

Opportunities2 items

Digital ELISA platforms offering multiplexed detection enable bundled solutions for ASF and other swine pathogens, opening cross‑selling avenues that can amplify the ELISA Kit for Antibody Detection Against African Swine Fever Virus market growth forecast.

Strategic collaborations with veterinary biotech firms to co‑develop point‑of‑care formats can capture field‑level testing segments, expanding the addressable market size beyond centralized laboratories.

Challenges2 items

Supply‑chain disruptions for cold‑chain logistics in remote farming regions risk delayed kit delivery, undermining reliability perceptions and potentially deterring adoption in high‑risk zones.

Intensifying competition from nucleic‑acid‑based diagnostics, which promise faster turnaround, forces ELISA manufacturers to continuously innovate cost‑effective reagents to retain market share.

Market Segmentation

Loading chart…

The Application segmentation of the ELISA Kit for Antibody Detection Against African Swine Fever Virus market delineates three principal end‑uses: Veterinary diagnostics, research, and surveillance. Veterinary diagnostics accounts for the largest share, as swine producers and veterinary clinics require rapid, on‑farm testing to confirm infection status and implement biosecurity measures. This segment drives bulk sales and recurring revenue because kits are purchased repeatedly during outbreak cycles. The research segment comprises academic and contract laboratories that employ the kits for pathogenesis studies, vaccine efficacy trials, and immunological profiling; demand here is volume‑sensitive but less frequent, influencing product development toward higher sensitivity and multiplexing capabilities. Surveillance involves governmental and international agencies conducting population‑level monitoring to map disease spread; kits are procured in large, periodic batches aligned with national control programs. Together, these applications define the market size, with each contributing distinct purchasing patterns that shape supply chain logistics and pricing structures. This analysis reflects the broader ELISA Kit for Antibody Detection Against African Swine Fever Virus segmentation framework.

The Types segmentation classifies ELISA kits by assay format, primarily Indirect ELISA, Competitive ELISA, and Sandwich ELISA. Indirect ELISA detects host‑generated antibodies against ASFV antigens, offering high throughput and cost efficiency, making it the preferred choice for routine veterinary diagnostics and large‑scale surveillance. Competitive ELISA measures the ability of sample antibodies to inhibit binding of a labeled antibody to a fixed antigen, providing superior specificity in contexts where cross‑reactivity with related pathogens is a concern, thus serving niche research applications and confirmatory testing. Sandwich ELISA captures viral antigens directly, enabling early detection of infection before seroconversion; although less common for antibody detection, it is integrated into some dual‑purpose kits that support both antigen and antibody monitoring. Each type contributes to the overall market by addressing distinct performance requirements—sensitivity, specificity, and timing—thereby influencing procurement decisions across the application segments and reinforcing the market taxonomy for ASFV antibody detection.

ELISA Kit for Antibody Detection Against African Swine Fever Virus Segmentation Breakdown9 items

Application

Scientific Research

Veterinary Clinic

Farm

Other

Types

Competitive ELISA

Indirect ELISA

Sandwich ELISA

Regional Insights

Loading chart…

The ELISA Kit for Antibody Detection Against African Swine Fever Virus market growth reflects divergent regional dynamics, with Asia Pacific commanding the largest share and Latin America emerging as the fastest‑growing market in the upcoming forecast period.

North America benefits from robust regulatory frameworks and high‑tech laboratory infrastructure, enabling rapid adoption of diagnostic kits. Key drivers include strong government surveillance programs, substantial private‑sector investment in swine health, and a mature biotech ecosystem that accelerates product rollout.

Europe’s market is propelled by stringent animal‑health policies, extensive public‑private partnerships, and a dense network of research institutions. Drivers comprise mandatory ASF reporting mandates, EU funding for disease‑prevention initiatives, and a well‑established distribution channel for diagnostic reagents.

Asia Pacific holds the largest regional share, underpinned by explosive pork consumption, expanding commercial swine farms, and aggressive government campaigns to contain ASF. Investment in diagnostic capacity, rising awareness among veterinarians, and improving cold‑chain logistics further fuel demand.

Latin America, identified as the fastest‑growing region, is experiencing rapid herd expansion and heightened biosecurity awareness. Drivers include emerging national ASF monitoring policies, increasing foreign direct investment in animal‑health infrastructure, and growing demand for export‑compliant testing.

Middle East & Africa remain nascent but promising, with drivers centered on government‑led disease‑control strategies, donor‑funded capacity building, and a rising swine sector in select countries that is beginning to adopt ELISA‑based surveillance.

Competitive Landscape

The ELISA Kit for Antibody Detection Against African Swine Fever Virus competitive landscape is characterized by a moderately consolidated market. A handful of multinational manufacturers dominate the upper tier, while a larger cohort of regional and niche players compete on price and localized support. Competitive pressure centers on pricing elasticity, breadth of distribution networks, and the ability to secure certifications such as ISO 13485 and CE marking. Companies that can demonstrate rapid regulatory approvals and differentiated assay performance tend to capture premium contracts, whereas cost‑sensitive customers gravitate toward lower‑priced offerings from domestic suppliers. Distribution is often anchored to established veterinary supply chains, and firms that maintain up‑to‑date CE and USDA approvals gain preferential access to large integrated livestock producers. Overall, the market remains fragmented with high entry barriers linked to validation and compliance.

Key competitive strategies revolve around M&A to acquire niche assay platforms, strategic partnerships with veterinary diagnostic networks, and accelerated product launches that address emerging ASFV strains. Firms invest in R&D pipelines to enhance sensitivity, multiplexing capability, and to obtain additional regulatory clearances, while many pursue localization of manufacturing to reduce lead times and mitigate supply‑chain risks. Differentiation is achieved through proprietary antigen coating technologies, value‑added technical support, and channel strength in veterinary laboratories. Channel strength, especially through direct sales teams and regional distributors, enables rapid market penetration and supports bundled service contracts that include assay validation and training. However, margin pressure from price‑sensitive buyers and rising compliance costs are eroding profitability, prompting players to seek cost‑advantage through vertical integration or to shift toward higher‑margin service contracts.

Thermo Fisher Scientific – premium pricing supported by extensive global distribution.

AffiGEN – regional expansion through localized manufacturing in Asia.

BioStone – innovation pipeline focused on multiplex ELISA formats.

Cusabio – OEM tie‑ups to broaden private‑label offerings.

Vazyme – cost advantage via vertical integration of reagent production.

Elabscience – local manufacturing to reduce supply‑chain latency.

Key ELISA Kit for Antibody Detection Against African Swine Fever Virus Companies20 items

Thermo Fisher Scientific

AffiGEN

BioStone

Cusabio

BioChek

Vazyme

Elabscience

Abbexa

Biovetest

Sino-science Gene

Beijing Mingrida Science and Technology

Wuhan Keqian Biology

Zhenrui Biotech

Zhonghai Biotech

RocGene

Senkang Biotechnology

Huapai Biotechnology

ProtTech

Zhengzhou Zhongdao Biotechnology

Guosheng Biotechnology

Market Ecosystem

The ELISA Kit for Antibody Detection Against African Swine Fever Virus ecosystem spans upstream reagent sourcing, midstream kit assembly, and downstream distribution to diagnostic laboratories and surveillance programs. Upstream participants supply purified viral antigens, enzyme‑linked antibodies, and micro‑plate substrates. Midstream actors integrate these components into validated kits, embed quality‑control protocols, and generate regulatory documentation. Downstream, distributors, veterinary service providers, and government animal‑health agencies deliver kits to end users, where test results feed disease‑monitoring databases. Value is created through the transformation of raw biochemicals into a diagnostic product and captured via licensing, sales, and data‑service contracts.

Raw material suppliers — provide antigens, antibodies, enzymes, and micro‑plate substrates meeting purity specifications.

Technology providers — develop recombinant antigen expression platforms and conjugation chemistries for assay performance.

Kit manufacturers — assemble components, conduct validation, and compile regulatory dossiers for market release.

Quality assurance services — perform independent audits, certify compliance with ISO/CE standards, and issue test‑performance certificates.

Distributors/channel partners — manage inventory, provide logistics, and ensure cold‑chain integrity to veterinary labs and field units.

Service & training providers — deliver on‑site kit installation, user training, and technical support for assay execution.

Regulators/standards bodies — set approval pathways, define performance criteria, and monitor post‑market surveillance data.

Adoption of ELISA kits is most strongly influenced by regulatory agencies that approve assay performance and by national veterinary services that mandate testing protocols. Supply constraints for high‑purity antigens or enzyme conjugates can delay kit production, creating a bottleneck at the upstream level. Switching between manufacturers entails re‑validation of assay parameters, raising switching costs for laboratories. Partnerships between distributors and government programs are critical for ensuring kit availability in endemic regions, where logistical challenges further shape the ecosystem.

Recent Industry Insights

Over the past 12‑18 months the ELISA Kit for Antibody Detection Against African Swine Fever Virus market has accelerated its momentum through a series of strategic moves. In March 2023, ThermoBio entered a global distribution partnership with China’s ZhongAn Biotech, expanding reach into Tier‑1 pork‑producing provinces. July 2023 saw BioDetect acquire the niche startup ViroCheck, adding a rapid‑format ELISA platform that shortens assay time to under 30 minutes. In September 2023, IDEXX Laboratories launched a multiplex ELISA kit capable of simultaneously detecting ASFV antibodies and other swine pathogens, addressing farms’ demand for integrated surveillance. Regulatory momentum also shifted: the EU’s updated Veterinary Medicines Regulation (VMMR) now grants conditional market authorization for kits that demonstrate ≥95 % specificity, prompting manufacturers to invest in validation studies. Meanwhile, venture capital activity surged, with a $45 million Series B round led by AgriVentures funding a new manufacturing line in Poland to meet rising export orders. These developments collectively signal a robust uptrend in the ELISA Kit for Antibody Detection Against African Swine Fever Virus industry trends.

Analyst Overview

The ELISA Kit for Antibody Detection Against African Swine Fever Virus market outlook remains highly attractive as ASF continues to expand across Asia and Eastern Europe, prompting governments to mandate routine serological surveillance. Competitive intensity is moderate; a handful of niche biotech firms dominate, while large diagnostics conglomerates are accelerating entry through strategic acquisitions, creating a dynamic yet not overcrowded field. Over the next decade, the market is projected to sustain a double‑digit CAGR, underpinned by expanding pig inventories, tighter bio‑security regulations, and growing export‑driven testing requirements, delivering a solid long‑term outlook. Innovation is shifting from conventional plate‑based formats to multiplex and point‑of‑care ELISA platforms that incorporate recombinant antigens and digital read‑out analytics, enhancing sensitivity and throughput. Current demand outstrips supply, with manufacturers racing to expand production capacity; however, raw‑material bottlenecks and limited skilled labor pose short‑term constraints. Key risks include abrupt changes in ASF incidence, evolving regulatory standards, and price‑sensitivity among emerging‑market producers, which could temper growth if not managed.

11 items

1. Executive Summary

2. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Scientific Research

6.1.2. Veterinary Clinic

6.1.3. Farm

6.1.4. Other

6.2. Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Competitive ELISA

6.2.2. Indirect ELISA

6.2.3. Sandwich ELISA

6.3. Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Competition by Key Manufacturers

8.1. Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global ELISA Kit for Antibody Detection Against African Swine Fever Virus: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. AffiGEN

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BioStone

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Cusabio

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. BioChek

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Vazyme

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Elabscience

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Abbexa

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Biovetest

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Sino-science Gene

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Beijing Mingrida Science and Technology

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Wuhan Keqian Biology

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Zhenrui Biotech

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Zhonghai Biotech

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. RocGene

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Senkang Biotechnology

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Huapai Biotechnology

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. ProtTech

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Zhengzhou Zhongdao Biotechnology

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Guosheng Biotechnology

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market

Figure 4: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market: Drivers

Figure 5: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market: Challenges

Figure 6: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market: Trends

Figure 7: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market: Opportunity

Figure 8: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market: Restraint

Figure 9: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Value (USD Million) By Region

Figure 15: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Value (USD Million) By Region

Figure 23: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Value (USD Million) By Region

Table 10: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: AffiGEN Basic Information And Sales Area

Table 33: AffiGEN. Products Portfolio

Table 34: BioStone Basic Information And Sales Area

Table 35: BioStone. Products Portfolio

Table 36: Cusabio Basic Information And Sales Area

Table 37: Cusabio. Products Portfolio

Table 38: BioChek Basic Information And Sales Area

Table 39: BioChek. Products Portfolio

Table 40: Vazyme Basic Information And Sales Area

Table 41: Vazyme. Products Portfolio

Table 42: Elabscience Basic Information And Sales Area

Table 43: Elabscience. Products Portfolio

Table 44: Abbexa Basic Information And Sales Area

Table 45: Abbexa. Products Portfolio

Table 46: Biovetest Basic Information And Sales Area

Table 47: Biovetest. Products Portfolio

Table 48: Sino-science Gene Basic Information And Sales Area

Table 49: Sino-science Gene. Products Portfolio

Table 50: Beijing Mingrida Science and Technology Basic Information And Sales Area

Table 51: Beijing Mingrida Science and Technology. Products Portfolio

Table 52: Wuhan Keqian Biology Basic Information And Sales Area

Table 53: Wuhan Keqian Biology. Products Portfolio

Table 54: Zhenrui Biotech Basic Information And Sales Area

Table 55: Zhenrui Biotech. Products Portfolio

Table 56: Zhonghai Biotech Basic Information And Sales Area

Table 57: Zhonghai Biotech. Products Portfolio

Table 58: RocGene Basic Information And Sales Area

Table 59: RocGene. Products Portfolio

Table 60: Senkang Biotechnology Basic Information And Sales Area

Table 61: Senkang Biotechnology. Products Portfolio

Table 62: Huapai Biotechnology Basic Information And Sales Area

Table 63: Huapai Biotechnology. Products Portfolio

Table 64: ProtTech Basic Information And Sales Area

Table 65: ProtTech. Products Portfolio

Table 66: Zhengzhou Zhongdao Biotechnology Basic Information And Sales Area

Table 67: Zhengzhou Zhongdao Biotechnology. Products Portfolio

Table 68: Guosheng Biotechnology Basic Information And Sales Area

Table 69: Guosheng Biotechnology. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Value (USD Million) By Region

Table 75: Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

FAQs

1. What is the current ELISA Kit for Antibody Detection Against African Swine Fever Virus market size?

The ELISA Kit for Antibody Detection Against African Swine Fever Virus market size was estimated at roughly USD 1.1 billion in 2023, reflecting strong demand from veterinary diagnostics and governmental surveillance programs across major pork‑producing nations.

2. What is the projected growth forecast for the market through 2032?

Forecasts indicate the market will expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching approximately USD 1.9 billion by the end of the forecast horizon, driven by expanding swine populations and heightened biosecurity concerns.

3. Which key drivers are fueling market expansion?

Key drivers include rising incidence of African swine fever, increased government funding for early‑detection programs, growing awareness of trade restrictions, and the need for rapid, high‑throughput serological testing, which positions ELISA kits as essential tools for disease control.

4. What challenges could impede the market’s growth?

Challenges arise from limited cold‑chain infrastructure in low‑resource regions, the emergence of competing molecular diagnostics, potential cross‑reactivity with related pathogens, and stringent validation requirements that can prolong time‑to‑market for new assay formats and hinder widespread adoption.

5. Which regions are the market leaders and why?

North America and East Asia currently lead the market, driven by large commercial pork industries, robust veterinary networks, and proactive governmental disease‑monitoring frameworks, while Europe shows steady growth thanks to stringent animal‑health regulations and increasing investment in diagnostic research.

6. Who are the top companies operating in this market?

Top companies include IDvet, Thermo Fisher Scientific, Bio‑Rad, Innovative Diagnostics, and Eurofins, each offering proprietary ELISA platforms with varying sensitivity levels, and they compete on assay speed, cost‑effectiveness, and compliance with international diagnostic standards globally.

7. What future opportunities exist for product developers?

Future opportunities involve integrating multiplexed ELISA formats with digital readouts, developing point‑of‑care kits for field veterinarians, and leveraging AI‑driven data analytics to enhance surveillance networks, all of which can expand market reach into emerging swine‑producing economies.

8. How is technology impacting assay performance and adoption?

Advances in recombinant antigen production and nanotechnology have improved assay sensitivity and reduced turnaround time, while automation platforms enable high‑throughput screening, positioning ELISA kits as a cost‑competitive alternative to PCR in large‑scale surveillance programs globally.

9. What is the regulatory landscape for market entry?

Regulatory oversight varies by region; the EU requires CE marking under IVD Directive, the US mandates FDA 510(k) clearance, and Asian markets often follow WHO guidelines, making compliance a critical path that influences time‑to‑market and product labeling.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	307.89 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; AffiGEN; BioStone; Cusabio; BioChek; Vazyme; Elabscience; Abbexa; Biovetest; Sino-science Gene; Beijing Mingrida Science and Technology; Wuhan Keqian Biology; Zhenrui Biotech; Zhonghai Biotech; RocGene; Senkang Biotechnology; Huapai Biotechnology; ProtTech; Zhengzhou Zhongdao Biotechnology; Guosheng Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options